Cdk2 is required for p53-independent G2/M checkpoint control

PLoS Genetics

Volumn 6, Issue 2, 2010, Pages

  Chung, Jon H ^a   Bunz, Fred ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CELL CYCLE PROTEIN 6; CYCLIN DEPENDENT KINASE 2; PROTEIN P53; ATR PROTEIN, HUMAN; CDC6 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CHECKPOINT KINASE 1; NUCLEAR PROTEIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DNA REPLICATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MITOSIS; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN HCT116; ENZYME ACTIVATION; ENZYME STABILITY; METABOLISM; MOUSE; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RADIATION EXPOSURE;

MAMMALIA; MUS;

ANIMALS; CDC25 PHOSPHATASES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; CYTOPLASM; ENZYME ACTIVATION; ENZYME STABILITY; G2 PHASE; HCT116 CELLS; HUMANS; MICE; MITOSIS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77649230740     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000863     Document Type: Article

References (61)

1. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11): 630-641.
2. Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18(22): 2699-2711.
3. Hochegger H, Takeda S, Hunt T (2008) Cyclin-dependent kinases and cell-cycle transitions: Does one fit all? Nat Rev Mol Cell Biol 9(11): 910-916.
4. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 9(3): 153-166.
5. Berthet C, Kaldis P (2007) Cell-specific responses to loss of cyclin-dependent kinases. Oncogene 26(31): 4469-4477.
6. Tetsu O, McCormick F (2003) Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3(3): 233-245.
7. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P (2003) Cdk2 knockout mice are viable. Curr Biol 13(20): 1775-1785.
8. Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, et al. (2006) Combined loss of Cdk2 and Cdk4 results in embryonic lethality and rb hypophosphorylation. Dev Cell 10(5): 563-573.
9. Ortega S, Prieto I, Odajima J, Martin A, Dubus P, et al. (2003) Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 35(1): 25-31.
10. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, et al. (2004) Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118(4): 493-504.
11. Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, et al. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448(7155): 811-815.
12. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410(6830): 842-847.
13. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J (2002) The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 30(3): 290-294.
14. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D (2007) Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res 67(14): 6685-6690.
15. Satyanarayana A, Hilton MB, Kaldis P (2008) p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell 19(1): 65-77.
16. Martin A, Odajima J, Hunt SL, Dubus P, Ortega S, et al. (2005) Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 7(6): 591-598.
17. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282(5393): 1497-1501.
18. Waldman T, Kinzler KW, Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55(22): 5187-5190.
19. Hurley PJ, Wilsker D, Bunz F (2007) Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene 26(18): 2535-2542.
20. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, et al. (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288(5470): 1425-1429.
21. Sorensen CS, Syljuasen RG, Falck J, Schroeder T, Ronnstrand L, et al. (2003) Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3(3): 247-258.
22. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B (1999) 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401(6753): 616-620.
23. Pines J (1999) Four-dimensional control of the cell cycle. Nat Cell Biol 1(3): E73-9.
24. Aleem E, Kiyokawa H, Kaldis P (2005) Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 7(8): 831-836.
25. L'Italien L, Tanudji M, Russell L, Schebye XM (2006) Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines. Cell Cycle 5(9): 984-993.
26. Fung TK, Ma HT, Poon RY (2007) Specialized roles of the two mitotic cyclins in somatic cells: Cyclin A as an activator of M phase-promoting factor. Mol Biol Cell 18(5): 1861-1873.
27. Gong D, Pomerening JR, Myers JW, Gustavsson C, Jones JT, et al. (2007) Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 17(1): 85-91.
28. Mitra J, Enders GH (2004) Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 23(19): 3361-3367.
29. De Boer L, Oakes V, Beamish H, Giles N, Stevens F, et al. (2008) Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27(31): 4261-4268.
30. Furuno N, den Elzen N, Pines J (1999) Human cyclin A is required for mitosis until mid prophase. J Cell Biol 147(2): 295-306.
31. Moore JD, Yang J, Truant R, Kornbluth S (1999) Nuclear import of Cdk/cyclin complexes: Identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1. J Cell Biol 144(2): 213-224.
32. Yang J, Kornbluth S (1999) All aboard the cyclin train: Subcellular trafficking of cyclins and their CDK partners. Trends Cell Biol 9(6): 207-210.
33. Donzelli M, Draetta GF (2003) Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4(7): 671-677.
34. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, et al. (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A 97(19): 10389-10394.
35. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, et al. (2000) Chk1 is an essential kinase that is regulated by atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14(12): 1448-1459.
36. Zhao H, Piwnica-Worms H (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21(13): 4129-4139.
37. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, et al. (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8(1): 37-45.
38. Cortez D, Guntuku S, Qin J, Elledge SJ (2001) ATR and ATRIP: Partners in checkpoint signaling. Science 294(5547): 1713-1716.
39. Borlado LR, Mendez J (2008) CDC6: From DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 29(2): 237-243.
40. Clay-Farrace L, Pelizon C, Santamaria D, Pines J, Laskey RA (2003) Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1. EMBO J 22(3): 704-712.
41. Hermand D, Nurse P (2007) Cdc18 enforces long-term maintenance of the S phase checkpoint by anchoring the Rad3-Rad26 complex to chromatin. Mol Cell 26(4): 553-563.
42. Lau E, Zhu C, Abraham RT, Jiang W (2006) The functional role of Cdc6 in SG2/ M in mammalian cells. EMBO Rep 7(4): 425-430.
43. Liu L, Choi JH, Yim H, Choi JS, Park BD, et al. (2009) ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells. Int J Biochem Cell Biol 41(6): 1410-1420.
44. Oehlmann M, Score AJ, Blow JJ (2004) The role of Cdc6 in ensuring complete genome licensing and S phase checkpoint activation. J Cell Biol 165(2): 181-190.
45. Mailand N, Diffley JF (2005) CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 122(6): 915-926.
46. Melixetian M, Ballabeni A, Masiero L, Gasparini P, Zamponi R, et al. (2004) Loss of geminin induces rereplication in the presence of functional p53. J Cell Biol 165(4): 473-482.
47. Kan Q, Jinno S, Kobayashi K, Yamamoto H, Okayama H (2008) Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells. J Biol Chem 283(26): 17864-17872.
48. Kan Q, Jinno S, Yamamoto H, Kobayashi K, Okayama H (2008) ATP-dependent activation of p21WAF1/CIP1-associated Cdk2 by Cdc6. Proc Natl Acad Sci U S A 105(12): 4757-4762.
49. Lau E, Chiang GG, Abraham RT, JiangW (2009) Divergent S phase checkpoint activation arising from prereplicative complex deficiency controls cell survival. Mol Biol Cell 20(17): 3953-3964.
50. Nevis KR, Cordeiro-Stone M, Cook JG (2009) Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle 8(12): 1952-1963.
51. Yoshida K, Sugimoto N, Iwahori S, Yugawa T, Narisawa-Saito M, et al. (2010) CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells. J Cell Sci 123(Pt 2): 225-235.
52. Feng D, Tu Z, Wu W, Liang C (2003) Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res 63(21): 7356-7364.
53. Cimprich KA, Cortez D (2008) ATR: An essential regulator of genome integrity. Nat Rev Mol Cell Biol 9(8): 616-627.
54. Lovejoy CA, Xu X, Bansbach CE, Glick GG, Zhao R, et al. (2009) Functional genomic screens identify CINP as a genome maintenance protein. Proc Natl Acad Sci U S A 106(46): 19304-19309.
55. Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319(5868): 1352-1355.
56. Harper JW, Elledge SJ (2007) The DNA damage response: Ten years after. Mol Cell 28(5): 739-745.
57. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432(7015): 316-323.
58. Topaloglu O, Hurley PJ, Yildirim O, Civin CI, Bunz F (2005) Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Res 33(18): e158.
59. Rago C, Vogelstein B, Bunz F (2007) Genetic knockouts and knockins in human somatic cells. Nat Protoc 2(11): 2734-2746.
60. Smits VA, Reaper PM, Jackson SP (2006) Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 16(2): 150-159.
61. van Vugt MA, Bras A, Medema RH (2004) Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 15(5): 799-811.